Drugs / Multipotent Stromal Cells
last change Oct 2013 re-read 3 minutes ago

Multipotent Stromal Cells

Cell therapy

Developed for
acute kidney tubular necrosis
Investigated by
AlloCure Inc. · Intermountain Health Care, Inc. · St Mark's Hospital Foundation

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00733876 Aug 2008 → May 2010 acute kidney tubular necrosis AlloCure Inc. Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Multipotent Stromal Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00733876 ↗
Modality Cell therapy “bone marrow-derived, culture-expanded allogeneic mesenchymal stem cells” PMID 25018910 ↗ Sep 2011
Route Other “Intra-aortic Infusion” NCT00733876 ↗